← back to search

Yong Qiang

Nantong University · CN
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research focused on Thyroid nodules and Hepatocellular carcinoma, with related work in Cancer research, Thyroid, Cell growth. Notable publications include 'MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis', 'Circulating miR‐130b‐ and miR‐21‐based diagnostic markers and therapeutic targets for hepatocellular carcinoma', and 'Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma'.
h-index
citations
172
works
9
NIH funding
primary concept
email

Recent publications

Elastography for the diagnosis of high-suspicion thyroid nodules based on the 2015 American Thyroid Association guidelines: a multicenter study
BMC Endocrine Disorders 2020cited by 20position: middledoi
miR-20a/Foxj2 Axis Mediates Growth and Metastasis of Colorectal Cancer Cells as Identified by Integrated Analysis
Medical Science Monitor 2020cited by 13position: firstdoi
Elastography for the Diagnosis of High-Suspicion Thyroid Nodules Based on the 2015 American Thyroid Association Guidelines: A Multicenter Study
Research Square 2020cited by 2position: middledoi
Elastography for the Diagnosis of High-Suspicion Thyroid Nodules Based on the 2015 American Thyroid Association Guidelines: A Multicenter Study
Research Square 2020cited by 1position: middledoi
Circulating miR‐130b‐ and miR‐21‐based diagnostic markers and therapeutic targets for hepatocellular carcinoma
Molecular Genetics & Genomic Medicine 2019cited by 36position: middledoi
Clinical significance of CCBE1 expression in lung cancer
Molecular Medicine Reports 2017cited by 19position: middledoi
MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis
Tumor Biology 2016cited by 47position: middledoi
Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry 2016cited by 25position: middledoi
SYF2 is upregulated in human epithelial ovarian cancer and promotes cell proliferation
Tumor Biology 2015cited by 9position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jian Liu · UNSW Sydney1 papers (2015–2015)Jing Zhang · Nanchang University1 papers (2020–2020)Lei Yin · Wuhan University of Science and Technology1 papers (2016–2016)Jian Liu · Nanjing Forestry University1 papers (2020–2020)Feiran Wang · Sun Yat-sen University Cancer Center1 papers (2016–2016)Jianxin Zhong · Nantong University1 papers (2015–2015) · 1 papers (2020–2020)Shuyun Yang · Nantong University1 papers (2015–2015)Songbai Zhang · University of Illinois Urbana-Champaign1 papers (2020–2020)Liang Li · Tianjin University of Traditional Chinese Medicine1 papers (2020–2020)Lei Xiong · Massachusetts Institute of Technology1 papers (2017–2017)Sujuan Yan · South China Agricultural University1 papers (2015–2015) · 1 papers (2020–2020)Lirong Zhu · Jiangsu University1 papers (2016–2016)Qinghua Xi · Nantong University1 papers (2015–2015) · 1 papers (2020–2020)Haiwei Wu · Nanjing Medical University1 papers (2017–2017)Liu Lisha · Xinjiang Medical University1 papers (2020–2020)Wang Yan · Harbin Medical University1 papers (2020–2020)Renan Chang · Nantong University1 papers (2016–2016)